Business Description
Certara Inc
NAICS : 923120
SIC : 5045
ISIN : US15687V1098
Share Class Description:
CERT: Ordinary SharesTotal Employee Number:
1,576Description
Certara Inc accelerates medicines to patients using biosimulation software and technology to transform traditional drug discovery and development. It provides modeling and simulation, regulatory science, and assessment software and services to help clients reduce clinical trials, accelerate regulatory approval, and increase patient access to medicines. The company has its business presence in the Americas, which is also its key revenue-generating market, EMEA, and the Asia Pacific region.
Financial Strength
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Cash-To-Debt | 0.62 | |||||
Equity-to-Asset | 0.69 | |||||
Debt-to-Equity | 0.31 | |||||
Debt-to-EBITDA | 3.79 | |||||
Piotroski F-Score | 6/9 | |||||
Altman Z-Score | 1.99 | |||||
Beneish M-Score | -3.01 | |||||
WACC vs ROIC | ||||||
Growth Rank
5/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Revenue Growth Rate | 7.4 | |||||
3-Year EBITDA Growth Rate | 4.6 | |||||
3-Year EPS without NRI Growth Rate | -1.5 | |||||
3-Year FCF Growth Rate | -4.7 | |||||
3-Year Book Growth Rate | -0.4 |
Momentum Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
5-Day RSI | 51.55 | |||||
9-Day RSI | 54.31 | |||||
14-Day RSI | 56.88 | |||||
3-1 Month Momentum % | 44.15 | |||||
6-1 Month Momentum % | 10.44 | |||||
12-1 Month Momentum % | -30.91 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Current Ratio | 2.55 | |||||
Quick Ratio | 2.55 | |||||
Cash Ratio | 1.5 | |||||
Days Sales Outstanding | 74.88 | |||||
Days Payable | 8.81 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
3-Year Average Share Buyback Ratio | 0.1 | |||||
Shareholder Yield % | 6.42 |
Profitability Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Gross Margin % | 61.9 | |||||
Operating Margin % | -0.16 | |||||
Net Margin % | -16.75 | |||||
EBITDA Margin % | 19.29 | |||||
FCF Margin % | 13.36 | |||||
OCF Margin % | 20.29 | |||||
ROE % | -6.6 | |||||
ROA % | -4.54 | |||||
ROIC % | -0.05 | |||||
ROC (Joel Greenblatt) % | 19.21 | |||||
ROCE % | 0.19 | |||||
Years of Profitability over Past 10-Year | 1 | |||||
Moat Score | 7 | |||||
Tariff Resilience Score | 8 |
GF Value Rank
4/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
Forward PE Ratio | 24.18 | |||||
PE Ratio without NRI | 20.55 | |||||
PEG Ratio | 0.94 | |||||
PS Ratio | 3.21 | |||||
PB Ratio | 1.3 | |||||
Price-to-Free-Cash-Flow | 24.02 | |||||
Price-to-Operating-Cash-Flow | 15.77 | |||||
EV-to-EBIT | 536.67 | |||||
EV-to-Forward-EBIT | 9.38 | |||||
EV-to-EBITDA | 17.37 | |||||
EV-to-Forward-EBITDA | 8.1 | |||||
EV-to-Revenue | 3.35 | |||||
EV-to-Forward-Revenue | 2.65 | |||||
EV-to-FCF | 25.08 | |||||
Price-to-GF-Value | 0.67 | |||||
Price-to-Projected-FCF | 0.91 | |||||
Price-to-Peter-Lynch-Fair-Value | 0.82 | |||||
Earnings Yield (Greenblatt) % | 0.19 | |||||
FCF Yield % | 4.35 | |||||
Forward Rate of Return (Yacktman) % | 24.9 |
Operating Revenue by Business Segment
Operating Revenue by Geographic Region
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsGurus Latest Trades with NAS:CERT
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Peter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Certara Inc Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil $) | 408.45 | ||
| EPS (TTM) ($) | -0.45 | ||
| Beta | 1.4261 | ||
| 3-Year Sharpe Ratio | -0.34 | ||
| 3-Year Sortino Ratio | -0.49 | ||
| Volatility % | 50.18 | ||
| 14-Day RSI | 56.88 | ||
| 14-Day ATR ($) | 0.374142 | ||
| 20-Day SMA ($) | 8.1205 | ||
| 12-1 Month Momentum % | -30.91 | ||
| 52-Week Range ($) | 4.45 - 13.88 | ||
| Shares Outstanding (Mil) | 152.54 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 6 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Certara Inc Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Certara Inc Stock Events
| Event | Date | Price ($) | ||
|---|---|---|---|---|
| Fourth quarter earnings conference call for 2026 | 2027-02-26 08:30 | In 184 days | ||
| Annual report for 2026 | 2027-02-26 | In 183 days | ||
| Fourth quarter earnings results for 2026 | 2027-02-26 | In 183 days | ||
| Third quarter earnings conference call for 2026 | 2026-11-06 17:00 | In 72 days | ||
| Third quarter earnings results for 2026 | 2026-11-06 | In 71 days | ||
| Second quarter earnings conference call for 2026 | 2026-08-04 08:30 | 8.18 (-1.15%) | ||
| Second quarter earnings results for 2026 | 2026-08-04 | 8.18 (-1.15%) | ||
| Jefferies Global Healthcare Conference | 2026-06-03 13:20 | 5.62 (-6.95%) | ||
| William Blair\'s 46th Annual Growth Stock Conference | 2026-06-02 | 6.12 (+5.34%) | ||
| RBC CM Global Healthcare ConferenceDate | 2026-05-19 09:30 | 4.56 (+1.79%) |
Show
Entries
Certara Inc Frequently Asked Questions
What is Certara Inc(CERT)'s stock price today?
The current price of CERT is $8.22. The 52 week high of CERT is $13.88 and 52 week low is $4.45.
When is next earnings date of Certara Inc(CERT)?
The next earnings date of Certara Inc(CERT) is 2026-11-06 Est..
Does Certara Inc(CERT) pay dividends? If so, how much?
Certara Inc(CERT) does not pay dividend.
Press Release
Articles on Certara Inc
CERT SWOT Analysis: Financial Struggles Amidst Growth Opportunities Revealed in 10-Q Filing
Aug 05, 2026
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers